Zobrazeno 1 - 10
of 241
pro vyhledávání: '"Ute, Ganswindt"'
Autor:
Benedek Dankó, Julia Hess, Kristian Unger, Daniel Samaga, Christoph Walz, Axel Walch, Na Sun, Philipp Baumeister, Peter Y. F. Zeng, Franziska Walter, Sebastian Marschner, Richard Späth, Olivier Gires, Timm Herkommer, Ramin Dazeh, Thaina Matos, Lisa Kreutzer, Johann Matschke, Katharina Eul, Frederick Klauschen, Ulrike Pflugradt, Martin Canis, Ute Ganswindt, Joe S. Mymryk, Barbara Wollenberg, Anthony C. Nichols, Claus Belka, Horst Zitzelsberger, Kirsten Lauber, Martin Selmansberger
Publikováno v:
npj Precision Oncology, Vol 8, Iss 1, Pp 1-20 (2024)
Abstract Head and Neck Squamous Cell Carcinoma (HNSCC) is a heterogeneous malignancy that remains a significant challenge in clinical management due to frequent treatment failures and pronounced therapy resistance. While metabolic dysregulation appea
Externí odkaz:
https://doaj.org/article/478152ef0db84845b323352406d212bd
Autor:
Julian Mangesius, Thomas Seppi, Christoph Reinhold Arnold, Stephanie Mangesius, Johannes Kerschbaumer, Matthias Demetz, Danijela Minasch, Samuel Moritz Vorbach, Manuel Sarcletti, Peter Lukas, Meinhard Nevinny-Stickel, Ute Ganswindt
Publikováno v:
Current Oncology, Vol 31, Iss 4, Pp 1739-1751 (2024)
This study aims to evaluate the clinical outcome of stereotactic radiosurgery as the sole treatment for brain metastases and to assess prognostic factors influencing survival. A total of 108 consecutive patients with 213 metastases were retrospective
Externí odkaz:
https://doaj.org/article/680c2955c3aa4fffa2d63250fbe0da40
Autor:
Christoph Reinhold Arnold, Julian Mangesius, Iana Portnaia, Ute Ganswindt, Hendrik Andreas Wolff
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Despite a comparatively favorable prognosis relative to other malignancies, breast cancer continues to significantly impact women’s health globally, partly due to its high incidence rate. A critical factor in treatment failure is radiation resistan
Externí odkaz:
https://doaj.org/article/f1a50a20463b40f2a84c39ca83f9e0cb
Autor:
Asier Rabasco Meneghetti, Alex Zwanenburg, Annett Linge, Fabian Lohaus, Marianne Grosser, Gustavo B. Baretton, Goda Kalinauskaite, Ingeborg Tinhofer, Maja Guberina, Martin Stuschke, Panagiotis Balermpas, Jens von der Grün, Ute Ganswindt, Claus Belka, Jan C. Peeken, Stephanie E. Combs, Simon Böke, Daniel Zips, Esther G. C. Troost, Mechthild Krause, Michael Baumann, Steffen Löck
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) may benefit from personalised treatment, requiring biomarkers that characterize the tumour and predict treatment response. We integrate pre-treatment CT radiomics a
Externí odkaz:
https://doaj.org/article/c1dcd98b39744271b0c678eabb5a6b58
Autor:
Kristian Unger, Julia Hess, Vera Link, Alexander Buchner, Chukwuka Eze, Minglun Li, Christian Stief, Thomas Kirchner, Frederick Klauschen, Horst Zitzelsberger, Maximilian Niyazi, Ute Ganswindt, Nina-Sophie Schmidt-Hegemann, Claus Belka
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 39, Iss , Pp 100586- (2023)
Purpose: In prostate cancer, the indication to irradiate the pelvic lymphatic pathways in clinical node-negative patients is solely based on clinical nomograms. To define biological risk patterns of lymphatic spread, we studied DNA-methylation and ge
Externí odkaz:
https://doaj.org/article/ce00fc257e5d4dbfb1ffece614c15852
Autor:
Ulrike Schoetz, Diana Klein, Julia Hess, Seyd Shnayien, Steffen Spoerl, Michael Orth, Samet Mutlu, Roman Hennel, Anja Sieber, Ute Ganswindt, Benedikt Luka, Andreas R. Thomsen, Kristian Unger, Verena Jendrossek, Horst Zitzelsberger, Nils Blüthgen, Claus Belka, Steffen Unkel, Bertram Klinger, Kirsten Lauber
Publikováno v:
Cell Death and Disease, Vol 12, Iss 12, Pp 1-14 (2021)
Externí odkaz:
https://doaj.org/article/fbf13515bb4d4cd0a548292129080737
Autor:
Julian Mangesius, Christoph Reinhold Arnold, Thomas Seppi, Stephanie Mangesius, Mario Brüggl, Paul Eichberger, Ute Ganswindt
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 4776-4785 (2021)
The COVID-19 pandemic has an unprecedented impact on cancer treatment worldwide. We aimed to evaluate the effects of the pandemic on the radiation treatment of patients in order to provide data for future management of such crises. We compared the nu
Externí odkaz:
https://doaj.org/article/d3140c13b37f4cae94ec849629563d7d
Autor:
Karin A. Koinig, Christoph Arnold, Jens Lehmann, Johannes Giesinger, Stefan Köck, Wolfgang Willenbacher, Roman Weger, Bernhard Holzner, Ute Ganswindt, Dominik Wolf, Reinhard Stauder
Publikováno v:
Cancer Medicine, Vol 10, Iss 12, Pp 3928-3937 (2021)
Abstract Background To permit timely mitigation of adverse effects on overall clinical outcome, it is essential to understand how the pandemic influences distress and health‐related quality of life (HRQOL) in cancer patients during the coronavirus
Externí odkaz:
https://doaj.org/article/b6b4462dc6184c4fad619df0210a831e
Autor:
Paul Rogowski, Christian Trapp, Rieke von Bestenbostel, Nina-Sophie Schmidt-Hegemann, Run Shi, Harun Ilhan, Alexander Kretschmer, Christian Stief, Ute Ganswindt, Claus Belka, Minglun Li
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-11 (2021)
Abstract Background The aim of this work was to investigate the outcome of metastasis-directed radiotherapy (MDT) in prostate cancer patients with bone metastases following current ESTRO/EORTC subclassifications for oligometastatic disease. Methods C
Externí odkaz:
https://doaj.org/article/2c2ed3a934de45fca1d8451923e8be01
Autor:
Henrik Schinke, Theresa Heider, Timm Herkommer, Florian Simon, Alexandra Blancke Soares, Gisela Kranz, Daniel Samaga, Laura Dajka, Annette Feuchtinger, Axel Walch, Laura Valeanu, Christoph Walz, Thomas Kirchner, Martin Canis, Philipp Baumeister, Claus Belka, Cornelius Maihöfer, Sebastian Marschner, Ulrike Pflugradt, Ute Ganswindt, Julia Hess, Horst Zitzelsberger, Olivier Gires
Publikováno v:
Molecular Oncology, Vol 15, Iss 4, Pp 1040-1053 (2021)
Head and neck squamous cell carcinomas (HNSCCs) have poor clinical outcome owing to therapy resistance and frequent recurrences that are among others attributable to tumor cells in partial epithelial‐to‐mesenchymal transition (pEMT). We compared
Externí odkaz:
https://doaj.org/article/38a6ed8f49fc46aeb9c0fc77e0558f6a